Irreversible liver failure: Treatment by transplantation;Irreversibles Leberversagen: Transplantation als Behandlungsoption

Deutsches Arzteblatt International

Volumn 110, Issue 10, 2013, Pages 167-173

  Pascher, Andreas ^a   Nebrig, Maxim ^a   Neuhaus, Peter ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; STEROID; TACROLIMUS;

ACUTE GRAFT REJECTION; ACUTE LIVER FAILURE; ALCOHOL LIVER CIRRHOSIS; AUTOIMMUNE HEPATITIS; CHOLESTASIS; CHRONIC GRAFT REJECTION; CHRONIC LIVER DISEASE; GENETIC DISORDER; GERMANY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER CELL CARCINOMA; LIVER FAILURE; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; META ANALYSIS (TOPIC); NEPHROTOXICITY; NEUROTOXICITY; OPPORTUNISTIC INFECTION; OUTCOME ASSESSMENT; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE THROMBOSIS; PRIMARY SCLEROSING CHOLANGITIS; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SEX RATIO; SURVIVAL RATE; SYSTEMATIC REVIEW; VIRUS HEPATITIS; COMORBIDITY; GRAFT REJECTION; LIVER CIRRHOSIS; MORTALITY; POSTOPERATIVE COMPLICATION; PREVALENCE; RISK FACTOR; SURVIVAL; TREATMENT OUTCOME;

COMORBIDITY; GRAFT REJECTION; HUMANS; LIVER CIRRHOSIS; LIVER FAILURE; LIVER TRANSPLANTATION; POSTOPERATIVE COMPLICATIONS; PREVALENCE; RISK FACTORS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84906329081     PISSN: 18660452     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2013.0167     Document Type: Review

References (31)

1. Mathurin P, Moreno C, Samuel D, et al.: Early liver transplantation for severe alcoholic hepatitis. N Engl J Med 2011; 365: 1790-800.
2. Pfitzmann R, Schwenzer J, Rayes N, Seehofer D, Neuhaus R, Nüssler NC: Long-term survival and predictors of relapse after orthotopic liver transplantation for alcoholic liver disease. Liver Transpl 2007; 13: 197-205.
3. Weismüller TJ, Prokein J, Becker T, et al.: Prediction of survival after liver transplantation by pre-transplant parameters. Scand J Gastroenterol 2008; 43: 736-46.
4. Hughes SA, Wedemeyer H, Harrison PM: Hepatitis delta virus. Lancet 2011; 378: 73-85.
5. Ruemmele P, Hofstaedter F, Gelbmann CM: Secondary sclerosing cholangitis. Nat Rev Gastroenterol Hepatol 2009; 6: 287-95.
6. van Keimpema L, Nevens F, Adam R, et al.: Excellent survival after liver transplantation for isolated polycystic liver disease: an European Liver Transplant Registry study. Transpl Int 2011; 24: 1239-45.
7. Pinson CW, Moore DE: Liver transplantation is not indicated for cholangiocarcinoma. HPB (Oxford) 2003; 5: 203-5.
8. Grotz TE, Nagorney D, Donohue J, et al.: Hepatic epithelioid haemangioendothelioma: is transplantation the only treatment option? HPB (Oxford) 2010; 12: 546-53.
9. Heimbach JK, Gores GJ, Haddock MG, et al.: Liver transplantation for unresectable perihilar cholangiocarcinoma. Semin Liver Dis 2004; 24: 201-7.
10. Darwish Murad S, Kim WR, Harnois DM, et al.: Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 US Centers. Gastroenterology 2012; 143: 88-98.
11. Canbay A, Jochum C, Bechmann LP, et al.: Acute liver failure in a metropolitan area in Germany: a retrospective study (2002-2008). Z Gastroenterol 2009; 47: 807-13.
12. Ramirez CB, Doria C, di Francesco F, et al.: Anti-IL2 induction in liver transplantation with 93% rejection-free patient and graft survival at 18 months. J Surg Res 2007; 138: 198-204.
13. Magrin S, Craxi A, Fabiano C, et al.: Hepatitis C viremia in chronic liver disease: relationship to interferon-alpha or corticosteroid treatment. Hepatology 1994; 19: 273-9.
14. Fong TL, Valinluck B, Govindarajan S, et al.: Short-term predni - sone therapy affects aminotransferase activity and hepatitis C virus RNA levels in chronic hepatitis C. Gastroenterology 1994; 107: 196-9.
15. Liang W, Wang D, Ling X, et al.: Sirolimus-based immunosuppression in liver transplantation for hepatocellular carcinoma: a metaanalysis. Liver Transpl 2012; 18: 62-9.
16. Beckebaum S, Cicinnati V, Brokalaki E, et al.: CNI-sparing reg - imens within the liver transplant setting: experiences of a single center. Clin Transpl 2004; 215-20.
17. Watson CJ, Gimson AE, Alexander GJ, et al.: A randomized controlled trial of late conversion from calcineurin inhibitor (CNI)- based to sirolimus-based immunosuppression in liver transplant recipients with impaired renal function. Liver Transpl 2007; 13: 1694-702.
18. Gomez-Camarero J, Salcedo M, Rincon D, et al.: Use of everolimus as a rescue immunosuppressive therapy in liver transplant patients with neoplasms. Transplantation 2007; 84: 786-91.
19. Levitsky J: Operational tolerance: past lessons and future pros - pects. Liver Transpl 2011; 17: 222-32.
20. Bohne F, Martínez-Llordella M, Lozano J, et al.: Intra-graft expression of genes involved in iron homeostasis predicts the development of operational tolerance in human liver transplantation. J Clin Invest 2012; 122: 368-82.
21. Penninga L, Wettergren A, Chan AW, et al.: Calcineurin inhibitor minimisation versus continuation of calcineurin inhibitor treatment for liver transplant recipients. Cochrane Database Syst Rev 2012; 3: CD008852.
22. Treem WR: Liver transplantation for non-hepatotoxic inborn errors of metabolism. Curr Gastroenterol Rep 2006; 8: 215-23.
23. www.eurotransplant.org/cms/index.php?page=annual-reports. Annual report 2011. Last accessed on 23 December 2012.
24. Pascher A, Neuhaus P: Bile duct complications after liver transplantation. Transpl Int 2005; 18: 627-42.
25. Bekker J, Ploem S, de Jong KP: Early hepatic artery thrombosis after liver transplantation: a systematic review of the incidence, outcome and risk factors. Am J Transplant 2009; 9: 746-57.
26. Bachir NM, Larson AM: Adult liver transplantation in the United States. Am J Med Sci 2012; 343: 462-69.
27. Watt KD, Pedersen RA, Kremers WK, Heimbach JK, Charlton MR: Evolution of causes and risk factors for mortality post-liver transplant: results of the NIDDK long-term follow-up study. Am J Transplant 2010; 10: 1420-7.
28. Weber ML, Ibrahim HN, Lake JR: Renal dysfunction in liver transplant recipients: evaluation of the critical issues. Liver Transpl 2012; 18: 1290-301.
29. Bodro M, Sabé N, Lladó L, et al.: Prophylaxis versus preemptive therapy for cytomegalovirus disease in high-risk liver transplant recipients. Liver Transpl 2012; 18: 1093-9.
30. Pappas PG, Alexander BD, Andes DR, et al.: Invasive fungal infections among organ transplant recipients: results of the transplant- associated infection surveillance network. Clin Infect Dis 2010; 50: 1101-11.
31. O'Grady J: Livertransplantation for acute liver failure. Best Pract Res Clin Gastroenterol 2012; 26 : 27-33.